Get informed when a big investor buys or sells
+ Follow91.80
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
Amplia Therapeutics Limited (INNMF) currently reports a PEG ratio of 91.8. That is above the Healthcare sector average of -6.46. Use the charts on this page to explore Amplia Therapeutics Limited's PEG ratio history and peer comparisons.
Amplia Therapeutics Limited's PEG ratio of 91.8 is higher than the Healthcare sector average of -6.46. That is roughly 1520.6% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The PEG ratio is a valuation multiple that relates Amplia Therapeutics Limited's market price to a fundamental measure such as earnings, sales, or book value. At 91.8, INNMF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current PEG ratio of 91.8, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -6.46. From there, open related valuation or income-statement pages for Amplia Therapeutics Limited, and consider following INNMF for alerts when major investors trade the stock.
Amplia Therapeutics Limited is classified in the Healthcare sector. On PEG ratio, it currently shows 91.8 versus a sector average near -6.46. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INNMF with unrelated industries.